Campagne de collecte 15 septembre 2024 – 1 octobre 2024 C'est quoi, la collecte de fonds?

Volume 57; Issue 4-supp-S1

Main
Urology
Volume 57; Issue 4-supp-S1

Urology

Volume 57; Issue 4-supp-S1

1

Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations

Ronald Lieberman, William G Nelson, Wael A Sakr, Frank L Meyskens Jr., Eric A Klein, George Wilding, Alan W Partin, J.Jack Lee, Scott M Lippman

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 1012 KB

english, 2001

2

State of research for prostate cancer: Excerpt∗ from the report of the Prostate Cancer Progress Review Group

Donald J. Tindall, Peter J. Scardino

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 94 KB

english, 2001

3

Similarities of prostate and breast cancer: Evolution, diet, and estrogens

Donald S Coffey

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 246 KB

english, 2001

4

The molecular pathogenesis of prostate cancer: Implications for prostate cancer prevention

William G Nelson, Angelo M De Marzo, Theodore L DeWeese

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 568 KB

english, 2001

5

Agents, biomarkers, and cohorts for chemopreventive agent development in prostate cancer

Gary J Kelloff, Ronald Lieberman, Vernon E Steele, Charles W Boone, Ronald A Lubet, Levy Kopelovich, Winfred A Malone, James A Crowell, Howard R Higley, Caroline C Sigman

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 136 KB

english, 2001

6

Sustaining the effort for cancer prevention

Carolyn Aldigé

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 105 KB

english, 2001

7

Prostate cancer prevention agent development: Criteria and pipeline for candidate chemoprevention agents

William G Nelson, George Wilding

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 150 KB

english, 2001

8

Androgen antagonists: Potential role in prostate cancer prevention

Donald L Trump, Joanne A Waldstreicher, Geert Kolvenbag, Paul S Wissel, Blake L Neubauer

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 122 KB

english, 2001

9

Selective estrogen receptor modulators for the chemoprevention of prostate cancer

Mitchell S Steiner, Sharan Raghow, Blake L Neubauer

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 139 KB

english, 2001

10

Proapoptotic anti-inflammatory drugs

Charles Myers, Alane Koki, Rifat Pamukcu, William Wechter, Robert J Padley

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 114 KB

english, 2001

11

Tyrosine kinase inhibitors and signal transduction modulators: Rationale and current status as chemopreventive agents for prostate cancer

Raymond C Bergan, Doyle H Waggle, Stephen K Carter, Ivan Horak, William Slichenmyer, Michael Meyers

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 152 KB

english, 2001

12

Prostate cancer prevention strategies using antiproliferative or differentiating agents

Janet Walczak, Hadley Wood, George Wilding, Thomas Williams Jr, Charles W Bishop, Michael Carducci

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 123 KB

english, 2001

13

Other novel agents: Rationale and current status as chemopreventive agents

Anthony W Tolcher, Ann Kennedy, Robert J Padley, Noreen Majeed, Michael Pollak, Philip W Kantoff

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 114 KB

english, 2001

14

Antioxidant dietary supplements: Rationale and current status as chemopreventive agents for prostate cancer

Neil Eric Fleshner, Omer Kucuk

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 122 KB

english, 2001

15

New biologicals for prostate cancer prevention:: Genes, vaccines, and immune-based interventions

Allan J Pantuck, Amnon Zisman, Daniel Henderson, Deborah Wilson, Alain Schreiber, Arie Belldegrun

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 116 KB

english, 2001

16

New molecular approaches for identifying novel targets, mechanisms, and biomarkers for prostate cancer chemopreventive agents

Elizabeth D Williams, James D Brooks

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 94 KB

english, 2001

17

New concepts in the pathology of prostatic epithelial carcinogenesis

Angelo M De Marzo, Mathew J Putzi, William G Nelson

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 315 KB

english, 2001

18

Histological markers of risk and the role of high-grade prostatic intraepithelial neoplasia

Wael A Sakr, Alan W Partin

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 133 KB

english, 2001

19

Imaging and prostate cancer chemoprevention:: Current diagnosis and future directions

Peter J Littrup

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 622 KB

english, 2001

20

Magnetic resonance imaging and spectroscopic imaging: Improved patient selection and potential for metabolic intermediate endpoints in prostate cancer chemoprevention trials

John Kurhanewicz, Mark G Swanson, Penelope J Wood, Daniel B Vigneron

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 121 KB

english, 2001

21

Computer-assisted image analysis–derived intermediate endpoints

Charles W. Boone, Ronald Lieberman, Thomas Mairinger, Branko Palcic, James Bacus, Peter Bartels

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 125 KB

english, 2001

22

Prostate-specific antigen and new serum biomarkers for evaluation of chemopreventive agents

Alan W Partin, Leonard S Marks

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 252 KB

english, 2001

23

Oxidative stress in chemoprevention trials

Theodore L. DeWeese, Andrew M. Hruszkewycz, Lawrence J. Marnett

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 111 KB

english, 2001

24

Apoptosis as a biomarker in chemoprevention trials

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 90 KB

english, 2001

25

Angiogenesis as a potential biomarker in prostate cancer chemoprevention trials

Iqbal Unnisa Ali, Donald R Senger, Lois E.H Smith

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 689 KB

english, 2001

26

Telomerase activity modulation in the prevention of prostate cancer

Nam W. Kim, Andrew M. Hruszkewycz

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 940 KB

english, 2001

27

Sequence databases and microarrays as tools for identifying prostate cancer biomarkers

Lynette H Grouse, Peter J Munson, Peter S Nelson

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 858 KB

english, 2001

28

New technologies for biomarker analysis of prostate cancer progression: Laser capture microdissection and tissue proteomics

Cloud P Paweletz, Lance A Liotta, Emanuel F Petricoin III

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 256 KB

english, 2001

29

Standardization, analytical validation, and quality control of intermediate endpoint biomarkers

Robert W Veltri, M.Craig Miller, Gang An

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 401 KB

english, 2001

30

Potential target populations and clinical models for testing chemopreventive agents

Eric A Klein, Frank L Meyskens Jr

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 106 KB

english, 2001

31

Prostate-specific antigen–enhanced testing and risk stratification for chemoprevention trials

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 122 KB

english, 2001

32

African American men and hereditary/familial prostate cancer: Intermediate-risk populations for chemoprevention trials

Isaac J Powell, Frank L Meyskens Jr.

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 115 KB

english, 2001

33

A randomized, controlled chemoprevention trial of selenium in familial prostate cancer: Rationale, recruitment, and design issues

Anthony J Costello

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 111 KB

english, 2001

34

Randomized, controlled chemoprevention trials in populations at very high risk for prostate cancer: Elevated prostate-specific antigen and high-grade prostatic intraepithelial neoplasia

Larry C Clark, James R Marshall

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 102 KB

english, 2001

35

Chemoprevention for prostatic carcinoma: The role of flutamide in patients with prostatic intraepithelial neoplasia

Steven R. Alberts, Michael L. Blute

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 95 KB

english, 2001

36

The role of prostate needle biopsy in evaluation of chemopreventive agents

Leonard S Marks, Jonathan I Epstein, Alan W Partin

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 204 KB

english, 2001

37

Preprostatectomy: A clinical model to study stromal-epithelial interactions

Wlodek Lopaczynski, Andrew M Hruszkewycz, Ronald Lieberman

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 218 KB

english, 2001

38

Dietary trial in prostate cancer: Early experience and implications for clinical trial design

Dean M Ornish, Keith L Lee, William R Fair, Elaine B Pettengill, Peter R Carroll

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 97 KB

english, 2001

39

Chemoprevention trials in men with prostate-specific antigen failure or at high risk for recurrence after radical prostatectomy: Application to efficacy assessment of soy protein

Maarten C Bosland, Ikuko Kato, Jonathan Melamed, Samir Taneja, Herbert Lepor, Pablo Torre, Paul Walden, Anne Zeleniuch-Jacquotte, L.H Lumey

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 100 KB

english, 2001

40

Trial endpoints for drug approval in oncology: Chemoprevention

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 91 KB

english, 2001

41

Early clinical trials of chemopreventive and biologic agents: Designs, populations, and endpoints

Patricia Keegan, Barbara E Loughman

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 112 KB

english, 2001

42

Bayesian monitoring of a phase 2 chemoprevention trial in high-risk cohorts for prostate cancer

Heidi L Weiss, Donald A Urban, William E Grizzle, Kathleen A Cronin, Laurence S Freedman, Gary J Kelloff, Ronald Lieberman

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 123 KB

english, 2001

43

The Prostate Cancer Prevention Trial: Current status and lessons learned

Ian M Thompson Jr, Margaret Kouril, Eric A. Klein, Charles A Coltman, Anne Ryan, Phyllis Goodman

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 180 KB

english, 2001

44

Prostate cancer chemoprevention: Strategies for designing efficient clinical trials

Ronald Lieberman

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 208 KB

english, 2001

45

Quality of Life endpoints in prostate chemoprevention trials

Jeff A Sloan, Claudette Varricchio

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 120 KB

english, 2001

46

Validation of surrogate endpoint biomarkers in prostate cancer chemoprevention trials

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 210 KB

english, 2001

47

Introduction

Ronald Lieberman, William G Nelson

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 96 KB

english, 2001

48

Foreword

Donald J. Tindall

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 45 KB

english, 2001

49

Design considerations for efficient prostate cancer chemoprevention trials

J.Jack Lee, Ronald Lieberman, Jeff A Sloan, Steven Piantadosi, Scott M Lippman

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 164 KB

english, 2001